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ABSTRACT: Medicare was designed to deal primarily with the effects of acute illness, which 
was seen at the time of the program’s inception as the major threat to the health and financial 
security of the aged. While it has fulfilled this purpose reasonably well, demographic and other 
changes pose new challenges to Medicare and the health care system as a whole. Moreover, that 
system must deal with sub-par performance, both on cost and quality. This report, which 
examines Medicare’s efforts to play a more proactive role in the purchase of appropriate, high-
quality, and efficient health care for its beneficiaries, provides an overview of Medicare 
demonstrations, pilots, and other initiatives in two categories: chronic care and provider 
performance. The process of identifying, testing, evaluating, and implementing Medicare policy 
improvements is also discussed, and recommendations for improving that process are offered. 
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EXECUTIVE SUMMARY 
 
Medicare was designed to deal primarily with the effects of acute illness, which was 
seen at the time of the program’s inception as the major threat to the health and financial 
security of the aged. While it has fulfilled this purpose, demographic and other changes 
pose new challenges to Medicare and the health care system as a whole. 
 
As with many other countries, the population of the United States is aging, and 
the prevalence of chronic conditions is increasing. Yet our nation’s health care delivery 
and financing system is not set up to care for a population with complex, long-term 
medical needs. The performance of the U.S. health system, according to many cost and 
quality indicators, is subpar. Moreover, the Medicare program is faced with insolvency by 
the end of the next decade. To meet these challenges, Medicare must play a more 
proactive role in the purchase of appropriate, high-quality, and efficient health care for the 
elderly and disabled. 
 
In response to these imperatives, the Centers for Medicare and Medicaid Services 
(CMS) is developing an array of initiatives to address the evolving needs of the Medicare 
program and its beneficiaries. Many of these initiatives have been developed under CMS’s 
demonstration authority, which allows the agency to waive certain Medicare payment 
rules that determine what services are covered and how they are paid in order to test 
potential improvements; others have been specifically mandated by Congress. 
 
Initiatives to Improve Medicare’s Effectiveness and Efficiency 
Medicare has a number of initiatives, both under way and in development, aimed at 
improving the quality and coordination of services provided to its beneficiaries. These fall 
primarily into two categories: improving the availability and coordination of care for 
beneficiaries with chronic conditions; and improving the alignment between payment (as 
well as other incentives) and the quality and effectiveness of care. 
 
The majority of Medicare’s chronic care initiatives are focused on better ways to 
coordinate care for beneficiaries in the traditional Medicare fee-for-service program, but 
several such initiatives address the structural impediments that Medicare managed care 
plans have faced when it comes to serving beneficiaries with chronic conditions. 
 
CMS has launched several initiatives in recent years to encourage improved quality 
of care, placing emphasis first on public reporting of quality indicators in a variety of 
health care settings. The agency also is providing technical assistance to a wide range of 
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providers through its Quality Improvement Organizations (QIOs). In addition, CMS has 
developed demonstration projects to test ways of using financial incentives to encourage 
better performance by hospitals, physicians, and other providers. 
 
Moving from Demonstrations and Pilots to Program Improvements 
With pressure mounting to find ways to improve quality while also controlling the growth 
of Medicare spending, it is important to know what these initiatives have to tell us about 
whether policy should be changed and, if so, how. But resources currently available for 
that purpose are scarce. The availability of more funding—to help identify potential 
improvements and assess their likelihood of success, to develop appropriate design and 
implementation strategies, and to evaluate results in a timely but rigorous manner—would 
enhance our ability not only to identify and develop more (and more appropriate) 
initiatives, but also to translate those initiatives into better policy. 
 
In identifying, developing, testing, evaluating, and implementing Medicare 
improvements, policymakers face a number of hurdles. Suggestions for improving the 
process include the following: 
 
• Increase clarity and flexibility in the waiver approval process. The purpose of Medicare 
demonstrations should be to enhance the program’s value, and the process for 
identifying, developing, approving, and implementing them should be more 
transparent and explicitly based on criteria consistent with that purpose. One 
important requirement for approval of Medicare demonstrations is budget 
neutrality, which rightly was intended to protect the fiscal integrity of the 
program. However, budget neutrality as currently applied has become a strict and 
narrowly defined rule that can hinder the development of important new 
initiatives. The application of this requirement should take into account the fact 
that some policy changes may involve short-term costs but long-term benefits. 
Cross-program savings and costs must be considered as well, so that policy changes 
that reduce overall spending can be tested, even if they require spending increases 
in some individual programs; the same reasoning should be applied across levels of 
government. In addition, there should be allowances for considering policy 
changes that increase value, even if they do not reduce spending per se. 
• Expand the array of methods available for evaluating demonstration results. Medicare 
demonstrations are not conducted in laboratories but in a world in which the 
policy environment is constantly changing. Consequently, evaluations must deal 
with imperfect controls and incomplete data with which to account for mitigating 
factors. Moreover, in many cases some of the major objectives of the policy 
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change being tested are themselves difficult to measure, either because they are 
qualitative in nature or because no baseline data exist to determine whether the 
policy in question has had the hoped-for effect. Putting mechanisms in place that 
allow for continuous monitoring of demonstrations would help indicate directions 
not only for the development of new policies when the trials are completed but 
also for changes in the trials themselves as they proceed. 
The importance and time-sensitivity of information on potential policy changes 
calls attention to the shortcomings of the methodology currently available for 
evaluating demonstration results. The imperfect controls and incomplete data 
available in the real world in which policy is implemented and evaluated must be 
balanced with the need for rigorous testing of potential policy improvements. 
More resources are needed to develop new ways of providing timely results that 
meet the needs of policymakers while maintaining research standards that ensure 
scientific validity. 
• Establish a more explicit and transparent mechanism for moving from pilot to policy. 
Finally, once the demonstrations are done and evaluated, the process would benefit 
from a more explicit mechanism for translating what we learn from them into new 
policy. In some cases—the Medicare Health Support pilot is the most recent 
example—Congress gives Medicare (through the Secretary of Health and Human 
Services) the authority to continue or expand a trial, but most often additional 
action is required to effect the policy changes suggested by demonstration results. 
Even when independent evaluations of a mandated demonstration’s results are 
required by law, it can take years for the evaluation report to be cleared by the 
Executive Branch and transmitted to the Congress. Again, making the process 
transparent would help considerably, allowing more open discussion of policy 
changes of interest and their potential impacts. The designation of a regular vehicle 
for reporting the findings from demonstrations and other initiatives would provide 
a visible source of information and a platform for the open discussion of policy 
implications. Overall, a strategy for dissemination is needed, so that potential 
policy improvements can be implemented and their benefits realized in a timely 
and effective manner. 
 
New initiatives to improve the program should build on the experiences and 
lessons learned from demonstrations, with the ability to reshape interventions as they are 
implemented to maximize their effectiveness. These changes will help Medicare improve 
the quality and effectiveness of care while controlling the cost growth that threatens the 
program’s fiscal viability. 
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ENHANCING VALUE IN MEDICARE: 
DEMONSTRATIONS AND OTHER INITIATIVES 
TO IMPROVE THE PROGRAM 
 
 
INTRODUCTION 
The Medicare Program, created in 1965, was designed to ensure access to needed health 
care for the elderly—half of whom lacked insurance to protect them against the potentially 
catastrophic costs of major illness.1 It has served that purpose well for more than 40 years. 
Over that time, Medicare has become one of the most popular government programs, 
generating consistently high satisfaction levels among its now 43 million elderly and 
disabled beneficiaries. 
 
Medicare was designed to deal primarily with the effects of acute illness, which was 
seen at the time of its implementation as the major threat to the health and financial 
security of the aged. While the health care delivery and financing system in the United 
States remains largely oriented toward acute care, demographic and other trends are 
putting pressure on that system—and on Medicare particularly—to change. Health care 
spending overall is growing more rapidly than our economy can sustain, and Medicare 
faces the additional pressure of a wave of post-World War II baby boomers set to begin 
retiring within the next few years.2 
 
At the same time, for all we spend on health care, there are significant issues with 
the safety, quality, and efficiency of care, and that care is poorly coordinated across 
providers.3 This problem is especially important for Medicare, whose aged and disabled 
beneficiaries need and use more health care and are more likely to have chronic conditions 
than the rest of the population.4 Consequently, Medicare must play a more proactive role 
in making sure that appropriate, high-quality, and efficient health care is available for the 
elderly and disabled. 
 
In response to these imperatives, the Centers for Medicare and Medicaid Services 
(CMS) is developing an array of initiatives to address the evolving needs of the Medicare 
program and its beneficiaries. Many of these initiatives have been developed under CMS’s 
demonstration authority, which allows the agency to waive certain Medicare payment 
rules that determine what services are covered and how they are paid in order to test 
potential improvements; others have been specifically mandated by Congress. 
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This paper will describe two sets of initiatives: those intended to improve care for 
chronic conditions; and those aimed at providing incentives for better provider 
performance. In addition, the paper will discuss the process for identifying, developing, 
implementing, and evaluating these kinds of initiatives and using them to enhance value in 
the Medicare program, and it will also offer some suggestions for improving that process. 
 
THE NEED FOR ENHANCED VALUE 
Like many other countries, the United States population is aging. In 2000, the proportion 
of individuals age 65 and older in the U.S. was 12.5 percent; this share is projected to 
grow to 16.6 percent by 2020, an increase of one-third.5 Older individuals are more likely 
to have one or more chronic conditions. A 2004 Commonwealth Fund survey of older 
adults asked respondents if a physician had told them that they had any of six conditions—
hypertension or high blood pressure, heart disease or heart attack, cancer, diabetes, 
arthritis, or high cholesterol—and the rate of reported conditions increased significantly 
with age: 67 percent of respondents aged 50 to 64 cited at least one chronic condition, 
versus 84 percent of those aged 65 to 70.6 Other studies have shown that the 20 percent 
of Medicare beneficiaries with five or more chronic conditions account for 66 percent 
of Medicare spending (Figure 1)—and they receive services from an average of almost 
14 physicians in a given year.7 
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Figure 1. Two-Thirds of Medicare Spending Is for
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The health care delivery and financing system, however, is not set up to serve 
individuals with multiple chronic conditions. Studies have shown that Medicare 
beneficiaries with these conditions are more likely to have preventable hospitalizations, 
experience adverse drug interactions, undergo duplicate tests, and receive contradictory 
information from doctors.8 Moreover, the high Medicare costs they incur appear to be 
consistent over time: a 2005 Congressional Budget Office report found that nearly half of 
the beneficiaries in the top 25 percent of the Medicare population with respect to cost in 
1997 (a group that accounted for approximately 85 percent of total Medicare spending) 
were again in the top 25 percent the following year.9 That report also determined that of 
the high-cost beneficiaries in 2001, more than 75 percent had been diagnosed with one or 
more of seven major chronic conditions. 
 
Neither traditional fee-for-service Medicare nor Medicare Advantage (MA) is 
currently configured to provide adequate care for these beneficiaries. The fee-for-service 
payment model still dominates in the United States—particularly in Medicare. Although 
the proportion of Medicare beneficiaries enrolled in managed care arrangements has 
grown recently, about 85 percent of them remain in the traditional fee-for-service 
program, which provides no incentive for the coordinated care needed by the chronically 
ill.10 Additionally, fee-for-service payment encourages specific, condition-oriented care, 
by which an individual with multiple conditions is treated by multiple providers.11 
Moreover, the fee-for-service model allots more generous payments for procedures and 
specialists’ services, thereby discouraging physicians from entering the primary care fields 
that are more compatible with the role of care coordination. 
 
Although managed care would appear to be better suited to providing the kind of 
coordinated care needed by chronically ill Medicare beneficiaries, the MA program and its 
predecessors historically also have been flawed in this respect. Capitation can provide a 
strong incentive to avoid chronically ill enrollees if the payment system fails to adjust 
properly for the costliness of the individual enrollee and, although MA plan payment rates 
will be fully risk-adjusted in 2007, recent analyses indicate that the incentive to avoid 
sicker enrollees may persist.12 
 
Meanwhile, Medicare is likely to face increased fiscal pressure over the next few years: 
as baby boomers approach retirement, the country’s ratio of workers to beneficiaries is 
declining. As a result of the aging population and the new drug benefit, the Medicare Trustees 
estimate that program expenditures will grow from $336 billion in 2005 to $817 billion in 
2015 (Figure 2).13 Medicare spending as a share of gross domestic product (GDP)—at 2.7 
percent in 2005—is expected to rise to 4.7 percent by 2020. In addition, the Medicare 
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Hospital Insurance Trust Fund is projected to be insolvent by 2018. These projections will 
soon be pushed to the forefront of the political debate: the next (2007) Medicare Trustees’ 
Report is expected to trigger a “Medicare funding warning,” which by law requires that 
the president submit a proposal to Congress to address Medicare spending growth.14 
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Figure 2. Growth in Medicare Expenditures, 1970–2015
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In addition to an aging population, the increased prevalence of chronic conditions, 
and rapid spending growth, the Medicare program and the health care system as a whole 
must also deal with sub-par performance on many cost and quality indicators. The 
National Scorecard on U.S. Health System Performance compiled by the Commonwealth 
Fund’s Commission on a High Performance Health System indicates that there is much 
room for improvement.15 The 16 percent of the United States’ GDP attributable to health 
spending is double the proportion of most industrialized countries; after a pause in the late 
1990s, this percentage has been growing more rapidly in recent years.16 Yet these greater 
expenditures do not appear to translate into better care, with the United States lagging 
behind other countries on indicators such as mortality and healthy life expectancy. 
 
Moreover, both the quality of care and the efficiency with which it is provided 
are highly variable.17 Multiple quality indicators demonstrate large variation between top 
and bottom groups of hospitals, states, and health plans. For example, although top-
performing hospitals reach 100 percent adherence to basic clinical guidelines for treating 
patients with heart attacks, congestive heart failure, and pneumonia, the national average 
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is only 84 percent.18 Variations also exist in mortality rates: an analysis of Medicare 
beneficiaries’ mortality rates over the years 2000–2002 indicates a spread of 33 percentage 
points between the risk-adjusted mortality ratios in the 10 percent of hospitals with the 
lowest rates and the 10 percent of hospitals with the highest rates.19 
 
This highly variable quality of care is delivered by a system that is too often poorly 
coordinated, which puts patients at risk and raises costs. Care coordination is necessary at 
the time of hospital discharge and during transitions following discharge. Yet, according to 
a 2005 Commonwealth Fund survey, only 67 percent of hospitalized patients in the 
United States reported having their medications reviewed at time of discharge, compared 
to as much as 86 percent in Germany.20 Additionally, a lack of discharge planning occurs 
all too frequently. On average, U.S. patients with congestive heart failure receive hospital 
discharge instructions only 50 percent of the time.21 
 
There is also wide variation across the country in spending per Medicare 
beneficiary and the quality of care (Figure 3). For beneficiaries with acute myocardial 
infarction, hip fracture, and colorectal cancer with resection, there are substantial 
differences in one-year risk-adjusted mortality rates following the initial hospital admission 
and in resource use over that period. Medicare annual payments for patients with three 
chronic conditions—diabetes, chronic obstructive pulmonary disease, and congestive heart 
failure—also vary greatly across regions.22 
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Another contributor to inefficiency is the lack of timely access to physicians for 
after-hours care and advice, which can lead to unnecessary use of the emergency room 
(ER). A cross-national survey of six nations found that 26 percent of U.S. adults use the 
ER for conditions that could have been treated by a primary care doctor, compared with 
6 percent to 9 percent in the lowest-rate countries.23 
 
Medicare’s role in addressing these issues is unique: comprising one-fifth of all 
personal health care spending, it is both highly vulnerable to the forces affecting the 
broader health system and potentially an important driver of change.24 The fact that 
Medicare is financed by a near-universal payroll tax and also by general tax revenues, 
together with the fact that almost everyone who turns 65 will become a Medicare 
beneficiary, make it particularly visible, important, and accountable to the American 
people. It is readily apparent that changes are needed, and Medicare can and must serve as 
a springboard for policies that improve health care, not only for its beneficiaries but also 
for the entire population. 
 
CMS has already begun to respond by developing a variety of initiatives aimed at 
improving the quality and coordination of services provided to Medicare beneficiaries. 
These initiatives are discussed below. 
 
INITIATIVES TO IMPROVE EFFECTIVENESS AND EFFICIENCY25 
This paper considers demonstrations, pilots, and other initiatives that fall primarily into 
two categories: improving the availability and coordination of care for beneficiaries with 
chronic conditions; and improving the alignment between payment (as well as other 
incentives) and the quality and effectiveness of care. 
 
Chronic Care Initiatives 
One dimension on which CMS has focused is improving its ability to provide the chronic 
care beneficiaries increasingly need.26 Beneficiaries with chronic conditions make up an 
increasing proportion of the Medicare population. Moreover, as previously discussed, 
patients with chronic conditions typically receive fragmented health care from multiple 
providers and multiple sites of care; this problem is amplified for beneficiaries with 
multiple chronic conditions. Not only is such disjointed care confusing and ultimately 
ineffective, it can present difficulties for patients, including an increased risk of medical 
errors. Additionally, the repeated hospitalizations that frequently accompany such care are 
extremely costly to both patients and Medicare. As the nation’s population ages, the 
number of chronically ill Medicare beneficiaries is expected to grow dramatically, with 
serious implications for access, quality, and Medicare spending. 
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In the private sector, managed care entities such as health maintenance 
organizations, as well as private insurers, disease management organizations, and academic 
medical centers, have developed a wide array of programs that combine adherence to 
evidence-based medical practices with better coordination of care across providers. These 
initiatives are based on the belief that disease management programs can improve medical 
treatment plans, reduce avoidable hospital admissions, and promote other desirable 
outcomes without increasing costs.27 
 
Two features make the case for disease management even stronger in the Medicare 
context than in the private sector. First, the greater prevalence of chronic illnesses among 
the Medicare population provides more opportunity for improving the appropriateness, 
effectiveness, and efficiency of care. Second, unlike private insurers, the Medicare program 
keeps its enrollees for life. This means that efforts to improve the coordination of care for 
chronic conditions can be consistently and continuously applied over a long period; it also 
means that the benefits of such efforts will accrue to the program rather than to some 
other payer. 
 
The demonstration projects conducted by CMS in this area are intended to test the 
value of alternative approaches to improving care for beneficiaries with chronic 
conditions, while also making Medicare a more aggressive and effective purchaser of this 
care.28 The majority of Medicare’s chronic care initiatives have focused on the 
coordination of care for chronically ill beneficiaries in the traditional Medicare fee-for-
service program, but several of them have addressed the structural impediments that 
managed care plans have faced in attempting to provide appropriate care to this 
population. These initiatives are summarized in Table 1, and in the following discussion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  8
Table 1. Chronic Care Initiatives 
Initiative Description 
Medicare Case Management 
Demonstration 
The first of the Medicare chronic care initiatives, designed to test case man-
agement for beneficiaries with catastrophic illnesses and high medical costs. 
Medicare Coordinated Care 
Demonstration 
To examine whether coordinated care programs can improve medical 
treatment plans, decrease avoidable hospital admissions, and further benefit 
chronically ill beneficiaries without increasing program costs. 
Medicare Disease Management 
Demonstration 
To evaluate the effect of disease management services, coupled with a 
prescription drug benefit, on the health outcomes of Medicare beneficiaries 
diagnosed with advanced-stage congestive heart failure, diabetes, or 
coronary disease. 
Medicare Health Support Pilot program to test population-based chronic care programs that provide 
self-care support, education, and coordination of care to beneficiaries. 
Care Management for High-Cost 
Beneficiaries Demonstration 
To study a variety of provider-centered care management models—
including intensive-care management, increased provider availability, 
structured chronic care programs, restructured physician practices, and 
greater flexibility in care settings—for high-cost beneficiaries. 
Special Needs Plans (SNPs) Authorized by the Medicare Modernization Act to focus on individuals 
with special needs, including beneficiaries who are institutionalized, dually 
eligible for Medicare and Medicaid, or suffering from severe or disabling 
chronic conditions. 
End-Stage Renal Disease (ESRD) 
Managed Care Demonstration 
To test the feasibility of year-round open enrollment in managed care for 
beneficiaries with ESRD. Each site provides service integration, case 
management, and extra benefits, and is paid a higher rate to reflect the 
additional costliness of enrollees with ESRD. 
ESRD Disease Management 
Demonstration 
To test the effectiveness of disease management models for increasing 
quality of care for ESRD patients while ensuring that this care is provided 
more effectively and efficiently. 
Source: CMS Web site, http://www.cms.hhs.gov. 
 
 
Improving Chronic Care in Fee-for-Service Medicare 
The first of the Medicare chronic care initiatives was the Medicare Case 
Management Demonstration, which studied the appropriateness of providing case 
management services to beneficiaries with catastrophic illnesses and high medical costs. 
This demonstration was implemented at three sites beginning in October 1993 and 
continued through November 1995.29 The target conditions and case management 
protocols differed across the sites, but all three generally focused on increased education 
regarding proper patient monitoring and management of the target condition. 30 The 
project evaluation found that, while the projects successfully identified and enrolled 
populations of Medicare beneficiaries likely to have much higher than average Medicare 
costs, there was an unexpectedly low level of enthusiasm for the project from beneficiaries. 
This was attributed to the lack of physician involvement or sufficiently focused 
interventions, and to the lack of a financial incentive to reduce Medicare spending. 
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The Medicare Coordinated Care Demonstration was mandated by Congress 
in the Balanced Budget Act of 1997. This project was designed to test whether providing 
coordinated care services to Medicare fee-for-service beneficiaries with complex chronic 
conditions could yield better patient outcomes without increasing program costs. The 
demonstration (and a similar parallel project) originally involved a total of 15 sites, both in 
urban and rural areas, that focused on complex chronic conditions, including: congestive 
heart failure; heart, liver, and lung diseases; diabetes; psychiatric disorders; Alzheimer’s 
disease or other dementias; and cancer.31 Enrollment in these programs began in April 
2002, and at its maximum reached about 21,000 patients in the intervention and control 
groups combined. However, the five largest programs accounted for almost 60 percent of 
the total enrollment, while three of them enrolled fewer than 100 beneficiaries in their 
intervention groups. 
 
Among the initial findings from the demonstration was that beneficiary 
recruitment in the fee-for-service market can be a challenge. The most successful of the 
programs had close ties to physicians and other providers, which helped reach the 
appropriate beneficiaries and overcome skepticism about enrolling. Although the 
evaluation results are not yet available, the programs overall appear to have been very well 
received both by enrolled beneficiaries and participating physicians. The initial term of the 
demonstration has ended, but most of the programs have been continued until more 
complete evidence on their performance can be collected and analyzed. 
 
The Medicare Disease Management Demonstration, mandated in the 
Benefits Improvement and Protection Act of 2000, was intended to provide disease 
management, as well as a comprehensive drug benefit, for up to 30,000 eligible 
beneficiaries. This project, which began in Spring 2004, was of particular interest because 
it was designed to provide the first indication of how well prescription drugs can be used 
to help chronically ill beneficiaries in the context of the Medicare program. The three sites 
selected were fully at risk for any increase in Medicare spending among their enrollees.32 
The sites encountered greater-than-anticipated difficulties in identifying and enrolling 
beneficiaries, however; and, given the magnitude of the risk they faced, the demonstration 
was unable to continue to conclusion. 
 
A major initiative mandated in the Medicare Modernization Act of 2003 (MMA) 
was the Medicare Voluntary Chronic Care Improvement Program, now known as 
Medicare Health Support. This pilot program, which was implemented in August 2005 
and will run for three years, was expected to involve about 160,000 beneficiaries at eight 
sites (Figure 4) around the United States with high prevalence of diabetes and congestive 
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heart failure.33 The participating organizations are responsible for increasing adherence to 
evidence-based care and reducing unnecessary hospital stays and emergency room visits in 
an entire geographic area.34 They each receive a per-beneficiary-per-month fee for their 
care coordination services, and in return are responsible for meeting quality, outcome, and 
patient satisfaction objectives while reducing total spending for their populations by at least 
5 percent. If they fail to meet these requirements, they are responsible for reimbursing 
Medicare up to the total amount of their fees. 
 
One unique aspect of this project is that, unlike the other initiatives described 
here—in which beneficiaries were recruited to participate by explicitly indicating a 
willingness to “opt in”—eligible beneficiaries in Medicare Health Support areas were 
assumed to be participating in the demonstration unless they explicitly indicated that they 
wanted to “opt out” of it. The evaluation of the success of each site in meeting goals 
related to clinical quality outcomes, beneficiary satisfaction, and impact on program 
spending will be based on comparisons of beneficiaries who participated in the pilot 
programs with similar groups of beneficiaries who had indicated they were willing to 
participate but were instead randomly assigned to a control group. Based on these results, 
the Secretary of Health and Human Services has the authority to expand the breadth and 
scope of this program. 
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Figure 4. Medicare Health Support Organizations and Locations
Source: “Medicare Health Support.” www.cms.hhs.gov (Accessed Nov. 20, 2006).
• LifeMasters Supported 
SelfCare, Inc. (Okla.)
• Health Dialogue Services 
Corp. (Western Pa.)
• American Healthways, Inc. 
(Washington, D.C., and Md.)
• McKesson Health 
Solutions, LLC (Miss.)
• CIGNA Health Support, LLC 
(Northwest Ga.)
• Aetna Health Management, 
LLC (Chicago, Ill.)
• Green Ribbon Health 
(Central Fla.)
• XLHealth Corp. (Select 
counties, Tenn.)
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Another project developed by CMS is the Care Management for High-Cost 
Beneficiaries Demonstration. This project, which began enrollment in Fall 2005 and is 
operating in six sites, aims to study various care management models for high-cost/high-
risk beneficiaries.35 It is explicitly designed to use provider-directed, rather than third-
party, models of chronic care management; and to test the ability of these sites to 
coordinate care for participating beneficiaries by providing them with clinical support 
beyond traditional settings to manage their conditions. As in Medicare Health Support, 
each of the sites in this demonstration receives a monthly fee for each beneficiary 
participating in the program and must achieve program savings while meeting established 
performance standards; otherwise, they must return all or part of their fee. The sites are 
employing a variety of features, including support programs for health care coordination, 
physician and nurse home visits, use of in-home monitoring devices, provider office 
medical records, self-care and caregiver support, education and outreach, tracking and 
reminders of individuals’ preventive care needs, 24-hour nurse telephone lines, behavioral 
health care management, and transportation services. 
 
Improving Chronic Care in Medicare Managed Care 
As mentioned earlier, several aspects of the financing mechanism that became an 
integral part of the managed care model—particularly in Medicare—are incompatible with 
the original vision of coordinated care as it applies to chronically ill enrollees. Although 
capitation should provide a strong incentive to help chronically ill enrollees manage their 
conditions and avoid expensive hospital stays, it also provides an even stronger incentive 
for plans to avoid chronically ill enrollees in the first place: they are much more costly 
than the average enrollee, and—although Medicare adjusts the payment rates that 
managed care plans receive for the higher anticipated costliness of some types of individual 
enrollees—this risk adjustment has been gradually phased in over 10 years (it will not take 
full effect until 2007). Thus, plans still face potentially severe financial penalties for making 
themselves attractive to chronically ill populations. Medicare managed care plans, 
moreover, were prohibited (until 2006) from specializing in subsets of the population. 
Consequently, a plan that was designed to be particularly well suited to treating 
beneficiaries with a particular condition or cluster of conditions (such as congestive heart 
failure, asthma, or other chronic respiratory diseases) also had to be prepared to offer the 
full range of services to the entire beneficiary population, which it might not have been 
prepared to do. 
 
One initiative intended to address this shortcoming is the inclusion in the MMA of 
a provision (Section 231) authorizing Special Needs Plans (SNPs). This provision allows 
for the creation of MA plans that focus on individuals with special needs, including 
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beneficiaries who are: institutionalized, dually eligible for Medicare and Medicaid, or 
suffering from severe or disabling chronic conditions. SNPs are not paid differently from 
other MA plans (so their payment will not be fully risk-adjusted until 2007), but—unlike 
other MA plans—they are permitted to target individuals in the specified groups, and 
CMS has been flexible in certain other MA administrative requirements as well. As of 
January 2006, there were 276 SNPs, with more than 600,000 enrollees: 226 SNPs, with 
nearly 500,000 enrollees, were approved for dual eligibles (a population that itself includes 
a high proportion of beneficiaries with chronic conditions); 37 SNPs, with about 40,000 
enrollees, were focused on institutionalized beneficiaries (many of whom are both dually 
eligible and suffering from chronic conditions); and 13 SNPs, with about 70,000 enrollees, 
were focused specifically on beneficiaries with chronic conditions.36 
 
A population that is particularly in need of better coordinated care is Medicare 
beneficiaries with End-Stage Renal Disease (ESRD); people with ESRD not only require 
dialysis but also have other chronic conditions. In 2003, there were 351,000 Medicare 
beneficiaries with ESRD, with Medicare spending an average of $46,330 per person for 
their health care.37 Despite their need for coordinated care, beneficiaries with ESRD are 
not permitted to enroll in MA plans unless they were enrolled prior to the onset of the 
condition, because of the extreme risk that this population presents. In an attempt to 
develop an approach that would permit these beneficiaries to participate in Medicare 
Advantage (then called the Medicare Risk Program), an ESRD Managed Care 
Demonstration was launched in 1996, with enrollment beginning in 1998. This 
demonstration was conducted at sites in California and Florida (with a third site in 
Tennessee discontinuing operations after enrolling just 50 beneficiaries).38 Each site 
provided service integration, case management, and extra benefits in exchange for being 
paid a higher payment rate (with adjustments to reflect the additional costliness of 
enrollees with ESRD). 
 
The evaluation concluded that enrollees in the demonstration fared as well as, or in 
some cases better than, a representative sample of fee-for-service comparison beneficiaries. 
However, government expenditures were found to be higher than if the same enrollees 
had remained in fee-for-service Medicare; this was because the demonstration enrollees 
were, on average, younger and healthier than the general ESRD population. Moreover, 
despite the increased payment by the government, the demonstration sites experienced 
financial losses in one case and only small gains in the other. 
 
With an extensively reworked risk adjustment mechanism that was thought to 
reflect better the costliness of ESRD enrollees, CMS in 2005 announced an ESRD 
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Disease Management Demonstration to test the capability of disease management 
models to increase quality of care while ensuring that this care is provided more effectively 
and efficiently.39 Enrollment in this new demonstration began at three sites in the fall of 
2005, with coverage beginning in January 2006.40 Under this demonstration, 5 percent of 
the plans’ fees are reserved for incentive payments related to quality improvement. 
 
Initiatives to Improve Provider Performance 
The need for explicit financial incentives to improve quality and effectiveness of care in 
Medicare is widely recognized. The Institute of Medicine (IOM) made such a 
recommendation in 2002 and the Medicare Payment Advisory Commission (MedPAC) 
called for incentive payments in 2004.41 In an open letter published in 2003, prominent 
health care leaders—including several former Administrators of CMS and its predecessor, 
the Health Care Financing Administration—called for Medicare to create financial 
incentives that promote the pursuit of improved quality.42 They noted that Medicare 
demonstration authority gives the agency the power to expand its programs for the testing 
of models, and they suggested that the Medicare Program should make quality 
improvement for hospital care in particular its immediate priority. Also, in the past few 
years, there have been several efforts on the part of private sector employers and payers to 
improve the quality of care through incentive programs. 
 
More recently, in its report on rewarding provider performance in Medicare, the 
IOM concluded that: “The overall quality of health care delivered to Americans is worse 
than it should be. While many quality improvement efforts have been undertaken, their 
success has been limited by current payment systems. The existing systems do not reflect 
the relative value of health care services in important aspects of quality . . . . Nor do 
current payment systems recognize or reward care coordination . . . . Fundamental 
changes in approaches to health care payment are necessary to remove impediments to 
and create incentives for significant quality improvement.”43 
 
These and similar findings have spurred an acceleration in the pace of activities 
aimed at improving the quality of care provided to Medicare beneficiaries. Moreover, 
with Medicare spending exceeding $375 billion in 2006, there is increasing pressure to 
improve the effectiveness of the program in obtaining the best possible outcomes for the 
resources that are expended. 
 
CMS has undertaken several initiatives in recent years to encourage improved 
quality of care, placing emphasis first on public reporting of quality indicators in a variety 
of health care settings. The agency is providing technical assistance to a wide range of 
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providers through its QIOs. Additionally, CMS has developed demonstration projects to 
test ways of providing financial incentives to encourage better performance. 
 
Initiatives Focused on the Reporting of Performance Measures 
There is evidence that the reporting of performance measures can enhance quality. 
A 2006 study by the National Committee for Quality Assurance found that health plans 
that collected and publicly reported performance data demonstrated broad-based 
improvements.44 Public reporting can be an incentive for group practices as well; groups 
that participate in public reporting tend to have higher performance.45 CMS has 
developed and implemented several initiatives involving the reporting of quality measures 
for private plans, nursing homes, home health agencies, hospitals, and physicians.46 These 
initiatives are summarized in Table 2 and in the discussion that follows. 
 
Table 2. Aligning Payment and Quality: 
Initiatives Focused on the Reporting of Performance Measures 
Initiative Description 
Nursing Home Quality Initiative Launched nationally in 2002, this initiative involves the reporting of 
post-acute and chronic care quality measures on the Nursing Home 
Compare Web site. 
Home Health Quality Initiative Launched in 2003, this initiative involves the reporting of quality 
measures relating to improvements in patient functionality on the Home 
Health Compare Web site. 
Hospital Quality Initiative This initiative began in 2003 with the voluntary reporting of a starter set 
of 10 hospital quality measures on the Hospital Compare Web site. The 
MMA provided a financial incentive for hospitals to report these 
measures, and the Deficit Reduction Act of 2005 expanded the set of 
measures and increased the amount of the financial incentive.  
ESRD Quality Initiative Measures of quality for dialysis facilities are available on the Dialysis 
Facility Compare Web site.  
Physician-Focused Quality Initiative The goals of this initiative, currently under development, are to develop 
measures of ambulatory care quality; develop and test means for 
measuring the quality of care for chronic diseases and preventive services 
provided in doctors’ offices; and support physicians’ adoption and 
effective use of information technology. 
Source: CMS Web site, http://www.cms.hhs.gov. 
 
The Nursing Home Quality Initiative was launched nationally in 2002 with 
the availability of post-acute and chronic care quality measures on the Nursing Home 
Compare Web site. This initiative focuses on both regulation and enforcement, as well as 
collaboration with Medicare’s QIOs, to improve the quality of care in nursing homes. 
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In 2003, the Home Health Quality Initiative began with a set of quality 
measures relating to improvements in patient functionality obtained from the Outcome 
and Assessment Information Set (OASIS) that is routinely collected from all Medicare home 
health agencies. These measures are available on the Home Health Compare Web site. 
 
Also in 2003, the Hospital Quality Initiative was started with voluntary 
reporting of a starter set of 10 hospital quality measures. The MMA provided hospitals 
with a financial incentive to report these measures, withholding 0.4 percent of their 
annual update in Medicare payments if they did not report them beginning in 2005—at 
which point compliance with the “voluntary” reporting rose to almost 100 percent. The 
Deficit Reduction Act of 2005 expanded the set of reportable measures required for 
hospitals to receive their full update to 21 and increased the amount of the withhold to 
2 percent of payments beginning in 2008. These measures are available on the Hospital 
Compare Web site. 
 
The ESRD Quality Initiative began in 2004, with posting of quality measures 
for dialysis facilities on the Dialysis Facility Compare Web site. In addition, CMS 
implemented a strategy to improve care by setting a goal of arterial venous fistula (AVF) 
utilization by 65 percent of dialysis patients by 2009 (AVF is the preferred method of 
vascular access for patients undergoing dialysis because it provides adequate blood flow, 
lasts longer than alternative methods, and has a lower complication rate). 
 
The Physician-Focused Quality Initiative includes: development of measures 
of ambulatory care quality and their endorsement by the National Quality Forum; 
implementation of a Doctor’s Office Quality (DOQ) project to develop and test a 
comprehensive and integrated approach to measuring the quality of care for chronic 
disease and preventive services in doctors’ offices; and a Doctor’s Office Quality 
Information Technology (DOQ-IT) project to support the adoption and effective use of 
information technology by physicians to improve quality and safety for Medicare 
beneficiaries and all patients. The DOQ-IT project puts Medicare’s QIOs in the role of 
providing infrastructure support for disseminating appropriate health care information 
technology and promoting its effective use. 
 
An additional part of the Physician-Focused Quality Initiative is the Physician 
Voluntary Reporting Program (PVRP). This is an effort to build on existing efforts to 
measure and stimulate improvements in the quality of care provided by physicians, by 
encouraging voluntary submission of specified quality data beginning in January 2006. The 
Tax Relief and Health Care Act of 2006 provides physicians with a 1.5 percent incentive 
payment beginning in July 2007 if they report on the PVRP measures in 2007. 
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Financial Incentives to Improve Provider Performance 
Efforts to improve quality and efficiency have gone beyond public reporting, with 
stakeholders across the country focusing on quality/payment alignment. At present, the 
private sector has more than 100 pay-for-performance programs in place. Concurrently, 
Medicare demonstrations have been examining such incentive systems in the public sector. 
Table 3 provides a summary of these demonstrations, which are then further discussed in 
the paragraphs that follow. 
 
Table 3. Aligning Payment and Quality: 
Financial Incentives to Improve Provider Performance 
Initiative Description 
Hospital Quality Incentive 
Demonstration 
More than 255 hospitals are voluntarily participating in this partnership between 
CMS and Premier, Inc., which began in October 2003. It includes a bonus on 
top of the DRG payment for top relative performers, and failure to exceed a 
fixed minimum performance threshold by the third year results in penalties. 
Physician Group Practice 
Demonstration 
This three-year project, which began in April 2005, includes 10 large multi-
specialty physician groups. Savings generated by each group relative to cost 
growth in its service area are shared between the group and Medicare, depending 
on both the amount of savings and the group’s achievement of quality targets. 
Medicare Care 
Management Performance 
Demonstration 
This project focuses on small to medium-sized practices in California, Arkansas, 
Massachusetts, and Utah. Its goal is to promote the adoption and use of health 
information technology to improve the quality of care for chronically ill patients. 
Nursing Home Pay-for-
Performance Demonstration
Under development, this initiative will provide financial rewards to nursing 
homes for meeting certain quality improvement standards and providing high-
quality care. 
Home Health Agencies Beginning in 2007, CMS will begin paying for the reporting of home health 
quality data. 
Medicare Participating 
Heart Bypass Center 
Demonstration 
This project was conducted to examine the feasibility, cost-effectiveness, and 
impact on quality of a negotiated all-inclusive bundled payment arrangement for 
coronary bypass graft surgery. 
Medicare Partnerships for 
Quality Cardiovascular 
Services and Quality Total 
Joint Replacement Services 
Demonstration 
This project was intended to assess whether bundled payments covering both 
hospital and physician services for certain high-volume, high-cost procedures 
would improve coordination and quality of care while achieving savings for 
Medicare. Plans to implement this demonstration were suspended, however. 
Medicare Health Care 
Quality Demonstration 
This five-year demonstration will test major changes in system design aimed both 
at improving quality of care and increasing efficiency. 
Physician Hospital 
Collaboration 
Demonstration 
This project will assess the effects of gainsharing on the quality of care in a health 
delivery system.  
Medicare Hospital 
Gainsharing Demonstration 
This demonstration will examine the use of gainsharing arrangements between 
hospitals and physicians to improve quality and efficiency of care. 
Source: CMS Web site, http://www.cms.hhs.gov. 
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CMS is testing models for rewarding hospitals that demonstrate high-quality 
performance. The Hospital Quality Incentive Demonstration, which started in 
October 2003, is a partnership between CMS and Premier, Inc., a nationwide purchasing 
alliance that includes some 1,500 not-for-profit hospitals. Participation in this demonstration 
is voluntary; as of January 2006, it included more than 255 hospitals. Rewards (and 
potential penalties) under the demonstration are based on 34 process and outcome 
measures that describe the quality of care for inpatients with five conditions: heart attack, 
heart failure, pneumonia, coronary artery bypass graft, and hip and knee replacements. 
 
Data on these measures are posted on the Medicare Web site, and top-performing 
hospitals are rewarded financially: hospitals ranking in the top 10 percent among the 
participating facilities for each condition receive a bonus equal to 2 percent of their 
Medicare payments for patients with that condition, while hospitals in the second decile 
for each condition are paid a 1 percent bonus. By the third year of the demonstration, 
hospitals that are performing relatively poorly (i.e., they fail to exceed performance 
requirements based on the distribution of scores in the first year) may be subject to 
decreased payments. For year one, CMS paid out a total of approximately $8.9 million in 
bonuses under this program, with incentive payments for individual hospitals of as much 
as $847,000.47 
 
Results from the first year indicate that hospital performance improved in every 
category, and this improvement appears to have taken place not only among the top 
hospitals but all the hospitals in the demonstration.48 Moreover, hospitals that were high 
performers on the quality measures also tended to have lower rates of readmissions, 
indicating that high quality and lower costs are compatible (Figure 5).49 
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Figure 5. Medicare Premier Hospital Demonstration:
Higher Quality Hospitals Have Fewer Readmissions
Readmission rates by pneumonia quality ranking (percent)
© 2005 Premier, Inc.
Source: Stephanie Alexander, “CMS/Premier Hospital Quality Incentive Demonstration Project: 1st Year Results,”
Presentation at Institute of Medicine Pay-for-Performance Subcommittee Meeting, Nov. 30, 2005.  
 
CMS is also testing financial incentives for physicians. The Physician Group 
Practice Demonstration, which began in April 2005, provides incentives for large 
multi-specialty group practices to improve the coordination of care for their Medicare fee-
for-service beneficiaries. The demonstration’s goals are to promote coordination of all 
Medicare services, encourage investment in administrative structure and process to 
increase efficiency, and reward physicians for improving health outcomes.50 The 10 sites 
participating in the demonstration represent more than 5,000 physicians and 200,000 fee-
for-service Medicare beneficiaries (Figure 6). 
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Figure 6. Medicare Physician Group Practice Demonstration
Source: M. Trisolini, G. Pope, J. Kautter, and J. Aggarwal, Medicare Physician Group Practices: 
Innovations in Quality and Efficiency (New York: The Commonwealth Fund, Dec. 2006).  
 
Each of the participating practices shares in any Medicare savings resulting from 
improved coordination and efficiency, with the size of the bonus depending on the 
difference between total Medicare spending for the patients assigned to the practice and a 
target amount. The target, in turn, is calculated from base-year spending for the patients 
assigned to the practice, inflated by growth in case-mix-adjusted per-capita spending for 
other beneficiaries in the practice’s service area. 
 
Medicare retains the first 2 percent of savings, and 80 percent of the remaining 
savings go into a bonus pool. Each practice will receive 70 percent of the amount in its 
bonus pool directly as a cost performance payment (this share falls to 60 percent in the 
second year and 50 percent in the third year). The other 30 percent of the practice’s bonus 
pool is distributed in accordance with the practice’s performance on a set of quality 
measures (this share rises to 40 percent in the second year and 50 percent in the third year). 
 
Across sites there has been a focus on improving care management and 
coordination of care; expanding palliative and hospice care; modifying physician practice 
patterns and behavior; and enhancing information technology.51 Initial results have been 
promising, but the bonus amounts for the first year have not yet been calculated and 
distributed (as of December 2006). 
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CMS is also expanding its pay-for-performance demonstrations to smaller 
physician practices. The Medicare Care Management Performance Demonstration, 
which will focus on solo and small to medium-sized practices, was recently announced. 
The goal of this demonstration, which was mandated in the MMA, is to promote the 
adoption and use of health information technology to improve the quality of care for 
chronically ill beneficiaries. CMS will implement this demonstration in Arkansas, 
California, Massachusetts, and Utah, and physicians who meet or exceed clinical 
performance standards will receive a bonus payment for managing the care of eligible 
Medicare beneficiaries. The demonstration also will allocate rewards based on how well 
practices do in the provision of preventive services. Payments under the demonstration 
include an initial payment for reporting baseline clinical quality measures; an annual 
payment based on the practice’s score on the clinical measures; and an additional annual 
bonus for reporting some or all of the measures electronically through an electronic health 
record system that meets the standards of the Certification Commission for Healthcare 
Information Technology.52 
 
One interesting aspect of the Medicare Care Management Performance 
Demonstration is that it is an expansion of the DOQ-IT initiative described earlier, with 
the Medicare QIOs providing technical assistance to participating practices so that they 
can meet the standards required for bonus payments. Another notable feature is that it is 
an attempt to adapt the model used in the Bridges to Excellence private sector initiative 
developed by General Electric, Verizon, FedEx, and several other large employers at 
several sites around the country; one of the Bridges to Excellence sites is the Boston area, 
which provides the opportunity to observe and evaluate the overlap and synergy between 
essentially similar (but not identical) private and public initiatives. 
 
In addition to the hospital and physician demonstrations described above, CMS is 
developing demonstrations that offer financial incentives to other types of providers. 
Under a Nursing Home Pay-for-Performance Demonstration, financial rewards 
would be provided to nursing homes that meet certain standards for delivering high-
quality care and also for quality improvement, facilitating the sharing of best practices.53 
For home health agencies, CMS will begin paying for the reporting of home health 
quality data in 2007, as mandated by the Deficit Reduction Act of 2005. 
 
Medicare also has implemented or is planning several initiatives that encourage 
collaboration between hospitals and physicians. For example, the Medicare 
Participating Heart Bypass Center Demonstration was conducted to assess the 
feasibility, cost-effectiveness, and impact on quality of a negotiated all-inclusive bundled 
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payment arrangement for coronary bypass graft surgery. The demonstration began with 
four sites in 1991, and was expanded to include three more sites in 1993.54 The evaluation 
indicated that all-inclusive bundled payment can provide an incentive to physicians and 
the hospital to work together to provide services more efficiently, improve quality, and 
reduce costs. The demonstration involved major changes in reimbursement arrangements, 
which, however, benefited some parties (such as patients, who had a single copayment 
amount) but were seen as a burden by others (such as hospitals, which were responsible 
for billing and collection).55 
 
Medicare developed the Medicare Partnerships for Quality Cardiovascular 
Services and Quality Total Joint Replacement Services Demonstration to test 
whether bundled payments covering both hospital and physician services for certain high-
volume, high-cost procedures would improve the coordination and quality of care 
provided to beneficiaries while achieving savings for the program. This demonstration had 
been conceived in the mid-1990s, but it was put on hold because of extensive system 
requirements mandated in the Balanced Budget Act of 1997 and additional Y2K-related 
changes; it was restarted in 2000. Applications were accepted from facilities in Michigan, 
Illinois, and Ohio, and the selection process was initiated, but plans to implement the 
demonstration were suspended in the fall of 2002, before final selections could be made, as 
the combination of delays and the difficulties in sorting out responsibilities among the 
various parties prevented the project from regaining its original momentum. 
 
A project with a very broad scope, the Medicare Health Care Quality 
Demonstration Program, was mandated by the MMA. This is a five-year project under 
which CMS will test major changes in system design aimed at improving quality of care 
while increasing efficiency. Unlike most other demonstrations, which are relatively limited 
in scope and intended to test specific types of changes in Medicare rules, the provision that 
mandated this program gives CMS broad flexibility to consider a range of payment systems 
designed to support significant changes in the organization of health care delivery. 
Organizations eligible to participate in the demonstrations are integrated delivery systems 
and regional consortia of providers. One round of applications for this program was due 
by the end of January 2006; CMS is (as of December 2006) in the process of finalizing the 
selection of several sites from that round. Another round of applications was due at the 
end of September 2006, and CMS has begun evaluating those as well. CMS has stated that 
it intends to choose a total of 8 to 12 sites to focus on improving the safety, effectiveness, 
efficiency, patient-centeredness, timeliness, and equity of the health care system.56 
 
 
  22
Further, under the umbrella of the Medicare Health Care Quality Demonstration 
CMS has announced that it is willing to consider the incorporation of financial and quality 
measurement and reporting models used in the Physician Group Practice Demonstration 
in proposals received from applicants that meet all of the goals of the Medicare Health 
Care Quality Demonstration and also have 150 or more physicians. 
 
In addition, CMS has, under the authority provided for the Medicare Health Care 
Quality Demonstration, developed a Physician Hospital Collaboration 
Demonstration—a three-year project to examine the effects of gainsharing aimed at 
improving the quality of care in a health delivery system. CMS has announced that it is 
particularly interested in demonstration designs that track patients well beyond a hospital 
episode. This will permit evaluation of the impact of hospital–physician collaborations on 
preventing short- and longer-term complications, avoiding duplication of services, 
coordinating care across settings, and making other improvements that eliminate 
preventable complications and reduce unnecessary costs. 
 
The Deficit Reduction Act of 2005 mandated a Medicare Hospital 
Gainsharing Demonstration to test different types of arrangements between hospitals 
and physicians designed to improve quality and efficiency of care provided to beneficiaries. 
This three-year demonstration will allow hospitals to provide physicians with gainsharing 
payments that represent solely a share of the savings incurred as a result of collaborative 
efforts to improve overall quality and efficiency. These arrangements are otherwise 
restricted by the civil monetary penalty law, which prohibits hospitals from rewarding 
physicians for reducing services to patients, even if such reductions are limited to 
duplicative services or otherwise represent improvements in quality.57 
 
MOVING FROM DEMONSTRATIONS AND PILOTS TO 
PROGRAM IMPROVEMENTS 
All of the demonstrations, pilot projects, and other initiatives described above are intended 
to find ways to change the way in which Medicare does business—to help Medicare move 
from its traditional role as a passive payer of health care bills to a more active purchaser of 
effective and efficient health care for its beneficiaries. 
 
With pressure mounting to find ways to improve quality while simultaneously 
controlling the growth of Medicare spending, it is increasingly important to be clear on 
what these initiatives have to tell us about whether and how policy should be changed. 
However, it is also increasingly difficult to find the resources needed to carefully study the 
results these initiatives produce. The availability of more resources—for research to help 
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identify potential improvements and assess their likelihood of success; for the development 
of appropriate design and implementation strategies; and for the evaluation of results—
would facilitate the translation of those initiatives into better policy. 
 
Moreover, the process of identifying, developing, testing, evaluating, and 
implementing Medicare policy improvements includes several hurdles. Here we discuss a 
few of those hurdles and offer some suggestions for lowering or eliminating them. 
 
One major problem in testing new and potentially productive ideas is the 
inflexibility of the waiver approval process. Franklin Roosevelt has been quoted as saying: 
“The country needs, and unless I mistake its temper, the country demands, bold, 
persistent, experimentation. It is common sense to take a method and try it. If it fails, 
admit it frankly and try another. But above all, try something.”58 With Medicare facing 
insolvency and quality of care in dire need of improvement, it is important to try new 
ideas that have a reasonable prospect of success in improving quality and efficiency. 
 
Another impediment to broad thinking in this regard is the requirement of budget 
neutrality for approval of new initiatives. This requirement and the way it is applied by the 
Office of Management and Budget (which has final approval of demonstration waivers) 
presents at least three difficulties. One problem is that budget neutrality is defined so 
strictly with regard to time that even a policy change that saves money in the intermediate 
or long run risks rejection because it may require some initial increase in federal spending. 
Another issue is that budget neutrality is defined separately for each federal program. 
Initiatives that reduce overall spending (improving coordination of Medicare and 
Medicaid for dual eligibles, for example) may not be considered budget neutral because 
one program may spend more while the other spends much less; the impact on other 
affected parties, such as states, is yet another complicating consideration. Moreover, the 
current application of the budget neutrality requirement does not allow for initiatives that 
substantially improve value even if they involve some extra spending. 
 
This shortsighted and overly restrictive interpretation of what in general is a 
reasonable criterion—but not the only reasonable criterion—for evaluating the potential 
merits of a new policy initiative hinders Medicare’s ability to develop and test 
improvements. It also fosters the view that CMS is more interested in reducing spending 
than improving the program. It is important to remember that Medicare (and Medicaid, 
for that matter) is not just a line item in the federal (or state) budget, but a social program 
that exists to provide access to necessary care to the population it serves. Ironically, this 
  24
narrow interpretation prevents CMS from implementing new policies that might both 
improve its programs and reduce overall public spending. 
 
Another problem that hinders the development of policy improvements is the 
limitations of the available methodology for evaluating their impact. Theoretically, 
demonstrations and pilots are carefully designed and implemented to adhere to strict 
methodological criteria in a carefully controlled environment. These types of social 
experiments, however, are not conducted in laboratories, but in a world in which the 
policy environment is constantly changing; the ability to maintain complete control over 
all aspects of such trials is limited. Consequently, although formal evaluations are 
conducted in most cases, those evaluations must deal with imperfect controls and 
incomplete data with which to control for mitigating factors. Moreover, in many cases 
some of the major objectives of the policy change being tested are difficult to measure, 
either because they are qualitative in nature or because no baseline data exist to determine 
whether the policy in question has had the hoped-for effect. New ways of evaluating the 
results of demonstrations and pilots and identifying their implications for the design of 
potential policy improvements would be useful for maintaining the appropriate balance 
between scientific rigor and policy usefulness. 
 
The timeliness of evaluations is also a chronic issue. Careful evaluation requires 
accurate and complete data, but the process of collecting, cleaning, and analyzing those 
data is not only inherently time-consuming but frequently either cannot begin until the 
initiative is over or has to start before the full effects of the trial have occurred. This can 
result in failure to act on potentially useful policy initiatives at the opportune moment or 
premature enactment of incompletely informed policy decisions. Mechanisms must be put 
in place that allow for continuous monitoring of evaluations, or perhaps bellwether 
measures can be developed that allow preliminary evaluations to help indicate directions 
not only for the development of new policies but also for changes in the trial itself. In any 
case, these issues call for a reexamination of the methodological tools at our disposal so 
that we can attain the best balance of scientific rigor and policy usefulness. 
 
Finally, the program would benefit from a more explicit mechanism for translating 
what we learn from demonstrations into new policy. In some cases—the Medicare Health 
Support pilot is the most recent example—the Congress gives Medicare (through the 
Secretary of Health and Human Services) the authority to continue or expand a trial, but 
most often additional action is needed in order to effect the policy changes suggested by 
demonstration results. Even when independent evaluations of a mandated demonstration’s 
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results are required by law, it can take years for the evaluation report to be cleared by the 
executive branch and transmitted to Congress. 
 
Again, making the process more transparent would help considerably, as this 
would allow more open discussion of policy changes of interest and their potential 
impacts. The designation of a regular vehicle for reporting the findings from 
demonstrations and other initiatives, such as in an issue of the Health Care Financing 
Review, would provide a visible mechanism for reviewing those results. Another such 
mechanism might be the annual reports produced by MedPAC. Those reports are widely 
distributed and consulted, and their release is generally followed by Congressional hearings 
to review their recommendations. 
 
CONCLUSIONS 
Medicare, being much in need of good ideas for policies that address the evolving needs of 
its beneficiaries and the health care system overall, has undertaken an array of initiatives—
and will pursue others in the future—to help it do that. 
 
In this paper, we suggest several ways of improving the process used to identify the 
policy issues that need to be addressed, design and implement the appropriate initiatives, 
evaluate their results, and then disseminate the indicated improvements to additional sites 
around the nation. To carry out these changes, more resources are required and several 
impediments to progress should be modified or eliminated. 
 
One needed improvement is increased clarity and flexibility in the demonstration 
approval process. The purpose of Medicare demonstrations should be to enhance the 
program’s value, and the process of identifying, developing, approving, and implementing 
them should be more transparent and explicitly based on criteria consistent with that purpose. 
 
A major requirement for approval of Medicare demonstrations is budget neutrality, 
which was rightly intended to protect the fiscal integrity of the program; however, budget 
neutrality as currently applied has become a strict and narrowly defined rule that can 
hinder the development of important new initiatives. The application of this requirement 
must take into account the fact that some policy changes may involve short-term costs but 
long-term benefits. Cross-program savings and costs must be considered as well, so that 
policy changes that reduce overall spending can be tested, even if they require spending 
increases in some individual programs; the same reasoning should be applied across levels 
of government. In addition, there should be procedures for considering policy changes 
that increase value, even if they do not reduce spending per se. 
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The methodology for evaluating demonstration results needs to be reexamined. 
We need to balance the imperfect controls and incomplete data available in the real world 
of policy analysis with the need for rigorous testing of potential policy improvements. This 
means developing ways of providing timely results that meet the needs of policymakers 
while maintaining research standards that ensure scientific validity. 
 
Finally, a more explicit and transparent mechanism for moving from pilot to 
policy must be established. The designation of a regular vehicle for reporting evaluation 
results would provide a visible source of information and a platform for the open 
discussion of their policy implications. Such a strategy of dissemination would enable 
potential policy improvements to be considered and implemented and their benefits 
realized in a timely manner. 
 
New initiatives to improve Medicare should build on the lessons learned from 
demonstrations, allowing interventions to be reshaped as they proceed to make them more 
effective. These changes will help improve the quality and effectiveness of health care 
while controlling the precipitous increases in cost that threaten the program’s 
fiscal viability. 
 
  27
NOTES 
 
 
1 K. Davis and S. R. Collins, “Medicare at Forty,” Health Care Financing Review, Winter 
2005–2006 27(2):53–62. 
2 The Commonwealth Fund Commission on a High Performance Health System, Why Not 
the Best? Results from a National Scorecard on U.S. Health System Performance (The Commonwealth 
Fund, Sept. 2006). 
3 Boards of Trustees, Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust 
Funds, 2006 Annual Report (Washington, D.C.: U.S. Government Printing Office, May 1, 2006). 
4 G. F. Anderson, “Medicare and Chronic Conditions,” New England Journal of Medicine, July 
21, 2005 353(3):305–09. 
5 G. F. Anderson and P. S. Hussey, “Population Aging: A Comparison Among Industrialized 
Countries,” Health Affairs, May/June 2000 19(3):191–203. 
6 S. R. Collins, K. Davis, C. Schoen, M. M. Doty, S. K. H. How, and A. L. Holmgren, 
Will You Still Need Me? The Health and Financial Security of Older Americans (New York: The 
Commonwealth Fund, June 2005). 
7 Partnership for Solutions, “Medicare: Cost and Prevalence of Chronic Conditions,” Fact Sheet 
(Baltimore: Johns Hopkins University and the Robert Wood Johnson Foundation, July 2002). 
8 J. L. Wolff, B. Starfield, and G. F. Anderson, “Prevalence, Expenditure, and Complications 
of Multiple Chronic Conditions and the Elderly,” Archives of Internal Medicine, Nov. 11, 2002 
162(20):2269–76. 
9 U.S. Congressional Budget Office, “High-Cost Medicare Beneficiaries” (Washington, D.C.: 
CBO, May 2005). 
10 U.S. Congressional Budget Office, “Fact Sheet for CBO’s March 2006 Baseline: Medicare” 
(Washington, D.C.: CBO, corrected Mar. 15, 2006). 
11 S. Guterman, “U.S. and German Case Studies in Chronic Care Management: An 
Overview,” Health Care Financing Review, Fall 2005 27(1):1–8. 
12 B. Biles, L. H. Nicholas, and S. Guterman, Medicare Beneficiary Out-of-Pocket Costs: Are 
Medicare Advantage Plans a Better Deal? (New York: The Commonwealth Fund, May 2006). 
13 Centers for Medicare & Medicaid Services, 2006 Annual Report of the Boards of Trustees of 
the Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds (Washington, 
D.C.: CMS, 2006), p. 30, http://www.cms.hhs.gov/ReportsTrustFunds/downloads/tr2006.pdf, 
accessed Oct. 2006. 
14 Henry J. Kaiser Family Foundation, “Medicare at a Glance,” fact sheet (Washington, D.C: 
Kaiser Family Foundation, July 2006). As specified in the Medicare Modernization Act of 2003, 
the “Medicare funding warning” is generated when the Medicare Trustees’ Reports in two 
consecutive years indicate that the proportion of Medicare spending from general revenues will 
exceed 45 percent within seven years. 
15 Commonwealth Fund Commission, Why Not the Best? 2006. 
16 G. F. Anderson, B. K. Frogner, R. A. Johns, and U. E. Reinhardt, “Health Care Spending and 
Use of Information Technology in OECD Countries,” Health Affairs, May/June 2006 25(3):819–31. 
17 Commonwealth Fund Commission, Why Not the Best? 2006. 
  28
 
18 C. Schoen, K. Davis, S. K. H. How, and S. C. Schoenbaum, “U.S. Health System 
Performance: A National Scorecard,” Health Affairs Web Exclusive (Sept. 20, 2006):w457–w475. 
19 Ibid. 
20 Commonwealth Fund Commission, Why Not the Best? 2006. 
21 Ibid. 
22 Schoen et al., “National Scorecard,” 2006. 
23 Commonwealth Fund Commission, Why Not the Best? 2006. 
24 Medicare Payment Advisory Commission, “National Health Care and Medicare Spending,” 
In A Data Book: Health Care Spending and the Medicare Program (Washington, D.C.: MedPAC, June 
2006). http://www.medpac.gov. 
25 The descriptions of the projects in this section are based on information at the Centers for Medicare 
& Medicaid Services Web site, http://www.cms.hhs.gov/DemoProjectsEvalRpts/MD/list.asp#, 
accessed Oct. 24, 2006. 
26 S. Guterman, “Eliminating Barriers to Chronic Care Management in Medicare,” testimony 
before the U.S. House of Representatives, Committee on Ways and Means, Subcommittee on 
Health, Feb. 25, 2006. 
27 By “disease management” we mean programs that are aimed at improving the quality and 
coordination of care for patients with single or multiple chronic conditions, in an effort to provide 
more effective care, eliminate avoidable acute care episodes, and improve outcomes. 
28 S. Guterman, “Disease Management in Traditional Medicare: A Square Peg in a Round Hole?” 
testimony before a Special Forum of the U.S. Senate, Special Committee on Aging, Nov. 4, 2003. 
29 Participating sites included AdminiStar Solutions, Iowa Foundation for Medical Care (IFMC), 
and Providence Hospital. AdminiStar Solutions recruited Medicare CHF patients throughout the 
state of Indiana; IFMC recruited Medicare CHF and COPD patients seen at any of 10 participating 
hospitals in Des Moines, western Iowa, and eastern Nebraska; and Providence Hospital (in 
Southfield, Mich.) took Medicare beneficiaries with CHF, COPD, or a range of other chronic 
problems who were patients of the hospital’s staff and resided in the Detroit metropolitan area. 
30 J. L. Schore, R. S. Brown, and V. A. Cheh, “Case Management for High-Cost 
Beneficiaries,” Health Care Financing Review, Summer 1999 20(4):87–101. 
31 The organizations originally participating in this demonstration were: Avera McKennan 
Hospital of Sioux Falls, S.D.; Carle Foundation Hospital of Urbana, Ill.; CenVaNet of Richmond, Va.; 
CorSolutions Medical, Inc. of Buffalo Grove, Ill. (site in Texas); Erickson Retirement Communities 
of Baltimore, Md.; Georgetown University Medical Center of Washington, D.C.; Hospice of the 
Valley of Phoenix, Ariz.; Jewish Home and Hospital of New York, NY; Mercy Medical Center of 
Mason City, Iowa; Medical Care Developments of Augusta, Maine; PennCARE of Allentown, Pa.; 
Quality Oncology, Inc., of McLean, Va. (site in Broward County, Fla.); QMED, Inc., of Laurence 
Harbor, N.J. (site in Northern Calif.); University of Maryland at Baltimore; and Washington 
University of St. Louis, Mo., with StatusOne Health of Hopkinton, Mass. (site in St. Louis, Mo.). 
32 The three participating sites were CorSolutions of Rosemont, Ill. (site in the Shreveport-
New Orleans corridor of La.); XLHealth of Baltimore, Md. (site in Texas); and HeartPartners of 
Santa Ana, Calif. (site in Calif. and Ariz.). 
33 As of December 2006, the number of beneficiaries participating in the demonstration was 
about 120,000, but one site—LifeMasters Supported SelfCare, Inc., operating in Oklahoma—was 
scheduled to drop out at the end of the month. 
  29
 
34 The organizations participating in Phase I of Medicare Health Support are LifeMasters 
Supported SelfCare, Inc. (site in Okla.); Health Dialog Services Corp. (site in Western Pa.); 
American Healthways, Inc. (site in Washington, D.C., and Md.); McKesson Health Solutions, LLC 
(site in Miss.); CIGNA Health Support (site in Northwest Ga.); Aetna Health Management, LLC 
(site in Chicago, Ill.); Green Ribbon Health (site in Central Fla.); and XLHealth Corp. (site in Tenn.). 
35 The organizations participating in this demonstration are ACCENT (site in Ore. and 
Wash.); Care Level Management (sites in Calif., Texas, and Fla.); Massachusetts General Hospital 
and Massachusetts General Physicians Organization (site in Boston, Mass.); Montefiore Medical 
Center (site in the Bronx, N.Y.); RMS Disease Management, LLC (site in Nassau and Suffolk 
Counties in N.Y.), and Texas Senior Trails (site in Texas panhandle area). 
36 U.S. Department of Health and Human Services, “Special Needs Plan—Fact Sheet & Data 
Summary” (Washington, D.C.: DHHS, Feb. 14, 2006). 
37 Health Care Financing Review Medicare and Medicaid Statistical Supplement, 2005 (July 2006), 
p. 56. 
38 Lewin Group and University Renal Research and Education Association, Final Report on the 
Evaluation of CMS’s ESRD Managed Care Demonstration (Falls Church, Va.: Lewin Group, June 2002). 
39 Centers for Medicare & Medicaid Services, “CMS Announces Demonstration Sites for 
Beneficiaries with End-Stage Renal Disease,” press release (Washington, D.C.: CMS, Oct. 31, 2005). 
40 The organizations participating in this demonstration are DaVita, with SCAN Health Plan 
(which is offering an MA SNP in parts of San Bernardino and Riverside Counties, Calif.); Fresenius 
Medical Care North America, with Sterling Life Insurance Co. (which is offering an MA private 
fee-for-service plan in Philadelphia and Pittsburgh, Pa., and Dallas, Houston, and San Antonio, 
Texas); and Fresenius Medical Care North America, with American Progressive Life and Health 
Insurance Co. (which is offering an MA private fee-for-service plan in Boston and Springfield, Mass.). 
41 Institute of Medicine, Leadership by Example: Coordinating Government Roles in Improving 
Health Care Quality (Washington, D.C.: National Academies Press, 2002); Medicare Payment 
Advisory Commission, Report to the Congress: Medicare Payment Policy (Washington, D.C.: 
MedPAC, Mar. 2004). 
42 D. M. Berwick, N. A. DeParle, D. M. Eddy, “Paying for Performance: Medicare Should 
Lead,” Health Affairs, Nov./Dec. 2003 22(6):8–10. 
43 Institute of Medicine, Rewarding Provider Performance: Aligning Incentives in Medicare 
(Washington, D.C.: National Academies Press, 2006), p. 1. 
44 S. C. Schoenbaum and A. L. Holmgren, The National Committee for Quality Assurance’s The 
State of Health Care Quality 2006 (New York: The Commonwealth Fund, Nov. 2006). 
45 S. M. Shortell, J. Schmittdiel, M. C. Wang et al., “An Empirical Assessment of High-
Performing Medical Groups: Results from a National Study,” Medical Care Research and Review, 
Aug. 2005 62(4):407–34. 
46 See “Quality Initiatives General Information” on the CMS Web site at 
http://www.cms.hhs.gov/qualityinitiativesgeninfo. 
47 Centers for Medicare & Medicaid Services, “Rewarding Superior Quality Care: The Premier 
Hospital Quality Incentive Demonstration,” fact sheet (Washington, D.C.: CMS, Jan. 2006). 
48 Premier, Inc., CMS/Premier Hospital Quality Incentive Demonstration Project: Findings from Year One 
(Charlotte, N.C.: Premier, Inc., 2006). 
  30
 
49 S. Alexander, “CMS/Premier Hospital Quality Incentive Demonstration Project: 1st Year 
Results,” Presentation at Institute of Medicine Pay-for-Performance Subcommittee Meeting, 
Nov. 30, 2005. 
50 Centers for Medicare & Medicaid Services, “Medicare Physician Group Practice 
Demonstration,” fact sheet (Washington, D.C.: CMS, Jan. 31, 2005). 
51 M. Trisolini, G. Pope, J. Kautter et al., “Medicare Physician Group Practice Site Meeting: 
Quality and Efficiency Innovations,” site meeting summary (New York: The Commonwealth 
Fund, forthcoming). 
52 Centers for Medicare & Medicaid Services, “Medicare Care Management Performance 
Demonstration,” demonstration summary (Washington, D.C.: CMS, 2006). 
53 Abt Associates, “Nursing Home Pay-for-Performance Demonstration Draft Design,” 
presentation at Centers for Medicare & Medicaid Services’ Open Door Forum, Sept. 20, 2005. 
54 The organizations originally participating in the demonstration were St. Joseph’s Hospital of 
Atlanta, Ga.; St. Joseph Mercy Hospital of Ann Arbor, Mich.; the Ohio State University Hospitals 
of Columbus, Ohio; and University Hospital of Boston, Mass. The three sites added in spring 
1993 were St. Luke’s Episcopal Hospital of Houston, Texas; St. Vincent’s Hospital of Portland, 
Ore.; and Methodist Hospital of Indianapolis, Ind. 
55 J. Cromwell, D. A. Dayhoff, N. T. McCall et al., “Medicare Participating Heart Bypass 
Center Demonstration,” final report (Washington, D.C.: Health Care Financing Administration, 
July 1998). 
56 Centers for Medicare & Medicaid Services, “Medicare Modernization Act, Section 646: 
Medicare Health Care Quality Demonstration Program,” fact sheet (Washington, D.C.: CMS, 2005). 
57 Centers for Medicare & Medicaid Services, “Medicare Hospital Gainsharing 
Demonstration,” fact sheet (Washington, D.C.: CMS, 2006). 
58 As quoted in A. Dobson, D. Moran, and G. Young, “The Role of Federal Waivers in the 
Health Policy Process,” Health Affairs Winter 1992 11(4):72–94. 
  31
RELATED PUBLICATIONS 
 
Publications listed below can be found on The Commonwealth Fund’s Web site at www.cmwf.org. 
 
 
State Strategies to Expand Health Insurance Coverage: Trends and Lessons for Policymakers (January 
2007). Alice Burton, Isabel Friedenzohn, and Enrique Martinez-Vidal. 
 
Public Reporting and Transparency (January 2007). John M. Colmers. 
 
Slowing the Growth of U.S. Health Care Expenditures: What Are the Options? (January 2007). Karen 
Davis, Cathy Schoen, Stuart Guterman, Tony Shih, Stephen C. Schoenbaum, and Ilana Weinbaum. 
 
The State Children’s Health Insurance Program: Past, Present, and Future (January 2007). Jeanne M. Lambrew. 
 
Medicare Physician Group Practices: Innovations in Quality and Efficiency (December 2006). Michael 
Trisolini, Gregory Pope, John Kautter, and Jyoti Aggarwal. 
 
Developing a Center for Comparative Effectiveness Information (November 7, 2006). Gail R. Wilensky, 
Health Affairs Web Exclusive (In the Literature summary). 
 
The Cost of Privatization: Extra Payments to Medicare Advantage Plans—Updated and Revised (November 
2006). Brian Biles, Lauren Hersch Nicholas, Barbara S. Cooper, Emily Adrion, and Stuart Guterman. 
 
The National Committee for Quality Assurance’s The State of Health Care Quality 2006 (November 
2006). Stephen C. Schoenbaum and Alyssa L. Holmgren. 
 
Why Not the Best? Results from a National Scorecard on U.S. Health System Performance (September 
2006). The Commonwealth Fund Commission on a High Performance Health System. 
 
Assessing Medicare Prescription Drug Plans in Four States: Balancing Cost and Access (August 2006). 
Erika Heaton, Tanisha Carino, and Heidi Dix. 
 
Medicare Physician Payment: Are We Getting What We Pay For? Are We Paying for What We Want? 
(July 25, 2006). Stuart Guterman. Invited testimony before the U.S. House of Representatives, 
Energy and Commerce Committee, Subcommittee on Health. 
 
Health Care Spending and Use of Information Technology in OECD Countries (May/June 2006). Gerard F. 
Anderson, Bianca K. Frogner, Roger A. Johns, and Uwe E. Reinhardt. Health Affairs, vol. 25, no. 3 
(In the Literature summary). 
 
Medicare Beneficiary Out-of-Pocket Costs: Are Medicare Advantage Plans a Better Deal? (May 2006). 
Brian Biles, Lauren Hersch Nicholas, and Stuart Guterman. 
 
Medicare at Forty (Winter 2005/2006). Karen Davis and Sara R. Collins. Health Care Financing 
Review, vol. 27, no. 2 (In the Literature summary). 
 
Medicare Extra: A Comprehensive Benefit Option for Medicare Beneficiaries (October 4, 2005). Karen 
Davis, Marilyn Moon, Barbara S. Cooper, and Cathy Schoen. Health Affairs Web Exclusive (In the 
Literature summary). 
 
Will You Still Need Me? The Health and Financial Security of Older Americans (June 2005). Sara R. 
Collins, Karen Davis, Cathy Schoen, Michelle M. Doty, Sabrina K. H. How, and Alyssa L. Holmgren. 
 
Prescription Drug Coverage and Seniors: Findings from a 2003 National Survey (April 19, 2005). Dana Gelb 
Safran, Tricia Neuman, Cathy Schoen et al. Health Affairs Web Exclusive (In the Literature summary). 
 
